$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000139681415000009 Filed on July 30, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$59.15M	$47.17M
YoY Change	25.41%	175.16%
Cost Of Revenue	$18.93M	$19.95M
YoY Change	-5.14%	95.36%
Gross Profit	$40.22M	$27.21M
YoY Change	47.8%	292.83%
Gross Profit Margin	68.0%	57.69%
Selling, General & Admin	$34.75M	$24.84M
YoY Change	39.92%	76.4%
% of Gross Profit	86.41%	91.28%
Research & Development	$3.649M	$5.216M
YoY Change	-30.04%	7.39%
% of Gross Profit	9.07%	19.17%
Depreciation & Amortization	$2.700M	$2.300M
YoY Change	17.39%	187.5%
% of Gross Profit	6.71%	8.45%
Operating Expenses	$57.33M	$50.01M
YoY Change	14.64%	71.54%
Operating Profit	$1.818M	-$2.842M
YoY Change	-163.97%	-76.34%
Interest Expense	$1.940M	$2.079M
YoY Change	-6.69%	8.62%
% of Operating Profit	106.71%
Other Income/Expense, Net	-$1.771M	-$2.195M
YoY Change	-19.32%	8.61%
Pretax Income	$47.00K	-$5.037M
YoY Change	-100.93%	-64.1%
Income Tax	$39.00K	$0.00
% Of Pretax Income	82.98%
Net Earnings	$8.000K	-$5.037M
YoY Change	-100.16%	-64.1%
Net Earnings / Revenue	0.01%	-10.68%
Basic Earnings Per Share		-$0.14
Diluted Earnings Per Share	$0.00	-$0.14
COMMON SHARES
Basic Shares Outstanding	36.48M shares	35.46M shares
Diluted Shares Outstanding	41.45M shares	35.46M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$153.1M	$163.9M
YoY Change	-6.59%	70.73%
Cash & Equivalents	$32.72M	$108.2M
Short-Term Investments	$120.4M	$55.70M
Other Short-Term Assets	$3.400M	$5.300M
YoY Change	-35.85%	47.22%
Inventory	$48.77M	$19.19M
Prepaid Expenses
Receivables	$24.28M	$20.55M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$229.6M	$208.9M
YoY Change	9.92%	71.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$77.81M	$53.51M
YoY Change	45.4%	27.22%
Goodwill	$27.12M	$12.52M
YoY Change	116.64%	39.42%
Intangibles
YoY Change
Long-Term Investments	$17.90M	$13.50M
YoY Change	32.59%
Other Assets	$2.252M	$3.103M
YoY Change	-27.43%	-16.41%
Total Long-Term Assets	$125.4M	$83.17M
YoY Change	50.73%	46.07%
TOTAL ASSETS
Total Short-Term Assets	$229.6M	$208.9M
Total Long-Term Assets	$125.4M	$83.17M
Total Assets	$355.0M	$292.1M
YoY Change	21.54%	63.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.30M	$3.145M
YoY Change	322.86%	83.7%
Accrued Expenses	$26.79M	$23.04M
YoY Change	16.3%	87.89%
Deferred Revenue
YoY Change
Short-Term Debt	$103.9M	$101.0M
YoY Change	2.87%
Long-Term Debt Due	$0.00	$900.0K
YoY Change	-100.0%	0.0%
Total Short-Term Liabilities	$145.5M	$129.5M
YoY Change	12.33%	717.85%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$5.447M	$4.384M
YoY Change	24.25%	59.83%
Total Long-Term Liabilities	$5.447M	$4.384M
YoY Change	24.25%	-95.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$145.5M	$129.5M
Total Long-Term Liabilities	$5.447M	$4.384M
Total Liabilities	$159.7M	$144.1M
YoY Change	10.83%	20.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$308.9M	-$312.9M
YoY Change	-1.3%	16.04%
Common Stock	$37.00K	$36.00K
YoY Change	2.78%	9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares
Shareholders Equity	$195.3M	$148.0M
YoY Change
Total Liabilities & Shareholders Equity	$355.0M	$292.1M
YoY Change	21.54%	63.69%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	$8.000K	-$5.037M
YoY Change	-100.16%	-64.1%
Depreciation, Depletion And Amortization	$2.700M	$2.300M
YoY Change	17.39%	187.5%
Cash From Operating Activities	$10.01M	$8.220M
YoY Change	21.78%	-161.76%
INVESTING ACTIVITIES
Capital Expenditures	-$14.67M	-$6.020M
YoY Change	143.69%	245.98%
Acquisitions
YoY Change
Other Investing Activities	-$6.170M	-$24.55M
YoY Change	-74.87%	549.47%
Cash From Investing Activities	-$20.85M	-$30.58M
YoY Change	-31.82%	453.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.650M	111.8M
YoY Change	-97.63%	9374.58%
NET CHANGE
Cash From Operating Activities	10.01M	8.220M
Cash From Investing Activities	-20.85M	-30.58M
Cash From Financing Activities	2.650M	111.8M
Net Change In Cash	-8.190M	89.44M
YoY Change	-109.16%	-606.74%
FREE CASH FLOW
Cash From Operating Activities	$10.01M	$8.220M
Capital Expenditures	-$14.67M	-$6.020M
Free Cash Flow	$24.68M	$14.24M
YoY Change	73.31%	-223.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12515000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36646879	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	9144000	USD
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
	pcrx	Adjustmentsto Additional Paidin Capital Issuanceof Common Stock Upon Conversionof Convertible Senior Notes AdjustmentstoAdditionalPaidinCapitalIssuanceofCommonStockUponConversionofConvertibleSeniorNotes	3930000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	243000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	241000	USD
CY2014Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	322000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	574000	USD
CY2015Q2	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	356000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	713000	USD
CY2014Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	0	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	0	USD
CY2015Q2	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	242000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	453000	USD
	pcrx	Compensationexpensefromstockoptions Compensationexpensefromstockoptions	5960000	USD
	pcrx	Compensationexpensefromstockoptions Compensationexpensefromstockoptions	13049000	USD
CY2014Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	3550000	USD
CY2015Q2	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6739000	USD
CY2014Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	1987000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	3552000	USD
CY2015Q2	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	-54000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	942000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2015Q2	pcrx	Conversion Request Convertible Senior Notes ConversionRequestConvertibleSeniorNotes	1500000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	1466000	USD
CY2015Q2	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	3100000	shares
CY2015Q2	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	219200000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	3930000	USD
CY2015Q2	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	3362000	USD
CY2014Q2	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-5037000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-16514000	USD
CY2015Q2	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	47000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	1359000	USD
CY2015Q2	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	377000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	276000	USD
CY2014Q4	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	103376000	USD
CY2015Q2	pcrx	Long Term Debt Including Royalty Interest Obligation LongTermDebtIncludingRoyaltyInterestObligation	103885000	USD
CY2014	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	2192000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	3362000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	0	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1195000	USD
CY2014Q4	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	276000	USD
CY2015Q2	pcrx	Royalty Interest Obligation RoyaltyInterestObligation	0	USD
CY2014Q4	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	276000	USD
CY2015Q2	pcrx	Royalty Interest Obligation Current RoyaltyInterestObligationCurrent	0	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
	pcrx	Stock Issued During Period Convertible Senior Notes Conversion StockIssuedDuringPeriodConvertibleSeniorNotesConversion	44000	shares
	pcrx	Stock Issued During Period Proceeds Followon Public Offering Issues StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues	110407000	USD
	pcrx	Stock Issued During Period Proceeds Followon Public Offering Issues StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues	0	USD
CY2015Q2	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	11200000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6758000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	13299000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22366000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24281000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28311000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26790000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20114000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25479000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-80000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-27000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	481334000	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	504146000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-4100000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14813000	USD
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5537000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9512000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7296000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14813000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2069000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2058000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7451000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7223000	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1738000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1530000	shares
CY2014Q4	us-gaap	Assets Assets	326072000	USD
CY2015Q2	us-gaap	Assets Assets	354993000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	214257000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	229626000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	143649000	USD
CY2015Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	138393000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	25000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	93000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	52000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108200000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37520000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32722000	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36150620	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36607839	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36150620	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36607839	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	36000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5073000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16550000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1321000	USD
CY2014Q4	us-gaap	Convertible Debt ConvertibleDebt	120000000	USD
CY2015Q2	us-gaap	Convertible Debt ConvertibleDebt	118534000	USD
CY2014Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	103100000	USD
CY2015Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	103885000	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	19954000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	38081000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	18929000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	36509000	USD
CY2015Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	3100000	shares
CY2015Q2	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days DebtInstrumentConvertibleThresholdConsecutiveTradingDays	P30D
CY2015Q2	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
CY2015Q2	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	16900000	USD
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	14649000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1426000	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1426000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	9508000	USD
CY2015Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8795000	USD
CY2014Q2	us-gaap	Depreciation Depreciation	2300000	USD
	us-gaap	Depreciation Depreciation	4300000	USD
CY2015Q2	us-gaap	Depreciation Depreciation	2700000	USD
	us-gaap	Depreciation Depreciation	5400000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4936000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5526000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	535000	USD
CY2015Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.83
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.07
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14597000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14758000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	403000	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	242000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-157000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2014Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	23761000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	27123000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5037000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-16514000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	352000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2238000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5037000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16514000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	47000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1359000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-305000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-879000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	91000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	159	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5226000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5018000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5955000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1915000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7426000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-713000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3637000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19506000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1263000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	38000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	332000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1032000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1509000	USD
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	113758000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6704000	USD
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3277000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3465000	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1680000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1782000	shares
CY2014Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	USD
CY2015Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	2079000	USD
	us-gaap	Interest Expense InterestExpense	4185000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	1940000	USD
	us-gaap	Interest Expense InterestExpense	3935000	USD
	us-gaap	Interest Paid InterestPaid	2583000	USD
	us-gaap	Interest Paid InterestPaid	2297000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11383000	USD
CY2015Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	23718000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	29263000	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	48769000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9263000	USD
CY2015Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11198000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8617000	USD
CY2015Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13853000	USD
CY2014Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	61000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	103000	USD
CY2015Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	177000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	332000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	154927000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	159714000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	326072000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	354993000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	140010000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	145472000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	103100000	USD
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	103885000	USD
CY2014Q4	us-gaap	Long Term Investments LongTermInvestments	24431000	USD
CY2015Q2	us-gaap	Long Term Investments LongTermInvestments	17941000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	95685000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-4798000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-21555000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-20646000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3482000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-5037000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-16514000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	8000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1268000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2195000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4415000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1771000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3799000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	50007000	USD
	us-gaap	Operating Expenses OperatingExpenses	95927000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	57330000	USD
	us-gaap	Operating Expenses OperatingExpenses	112305000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2842000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12099000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1818000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	5158000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	45426000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	7876000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	7660000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7459000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7263000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	11787000	USD
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3381000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2588000	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2252000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-36000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-36000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	53000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-36000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-36000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	53000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5409000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5447000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-41000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-77000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-74000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	13481000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9831000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22542000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	52992000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	92921000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4461000	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3429000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	56941000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	98179000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3351000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6975000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80746000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	103288000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60632000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77809000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5216000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10420000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3649000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9616000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1509000	USD
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2014Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
CY2015Q2	us-gaap	Restricted Stock Expense RestrictedStockExpense	369000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	369000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-310145000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308877000	USD
CY2014Q2	us-gaap	Revenues Revenues	47165000	USD
	us-gaap	Revenues Revenues	83828000	USD
CY2015Q2	us-gaap	Revenues Revenues	59148000	USD
	us-gaap	Revenues Revenues	117463000	USD
CY2014Q2	us-gaap	Royalty Expense RoyaltyExpense	136000	USD
	us-gaap	Royalty Expense RoyaltyExpense	256000	USD
CY2015Q2	us-gaap	Royalty Expense RoyaltyExpense	0	USD
	us-gaap	Royalty Expense RoyaltyExpense	71000	USD
CY2014Q2	us-gaap	Royalty Revenue RoyaltyRevenue	809000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1478000	USD
CY2015Q2	us-gaap	Royalty Revenue RoyaltyRevenue	730000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	1604000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5537000	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	46034000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	81776000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	58062000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	115146000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24837000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	47426000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34752000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	66180000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9512000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7296000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	14813000	USD
CY2015Q2	us-gaap	Share Price SharePrice	70.72
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	119138000	USD
CY2015Q2	us-gaap	Short Term Investments ShortTermInvestments	120425000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	19883	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1195000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6975000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	171145000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	195279000	USD
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	139000	USD
CY2015Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	72000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2015Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35463000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34587000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41445000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41612000	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35463000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34587000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36481000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36358000	shares

Files In Submission

Name	View Source	Status
0001396814-15-000009-index-headers.html	Edgar Link	pending
0001396814-15-000009-index.html	Edgar Link	pending
0001396814-15-000009.txt	Edgar Link	pending
0001396814-15-000009-xbrl.zip	Edgar Link	pending
exhibit101.htm	Edgar Link	pending
exhibit102.htm	Edgar Link	pending
exhibit103.htm	Edgar Link	pending
exhibit104.htm	Edgar Link	pending
exhibit105.htm	Edgar Link	pending
exhibit106.htm	Edgar Link	pending
exhibit107.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pcrx-20150630.xml	Edgar Link	completed
pcrx-20150630.xsd	Edgar Link	pending
pcrx-20150630_cal.xml	Edgar Link	unprocessable
pcrx-20150630_def.xml	Edgar Link	unprocessable
pcrx-20150630_lab.xml	Edgar Link	unprocessable
pcrx-20150630_pre.xml	Edgar Link	unprocessable
pcrx-63015xex311.htm	Edgar Link	pending
pcrx-63015xex312.htm	Edgar Link	pending
pcrx-63015xex321.htm	Edgar Link	pending
pcrx-63015xex322.htm	Edgar Link	pending
pcrx-6302015x10xq.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2015 Q2 Form 10-Q Financial Statement

#000139681415000009 Filed on July 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2015 Q2 Form 10-Q Financial Statement

#000139681415000009 Filed on July 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx